TipRanks
Advertisement
Advertisement
Valion Bio Inc trading halted, news pending
PremiumThe FlyValion Bio Inc trading halted, news pending
26d ago
Valion Bio Enacts Reverse Stock Split to Maintain Listing
Premium
Company Announcements
Valion Bio Enacts Reverse Stock Split to Maintain Listing
27d ago
Valion Bio announces 1-for-25 reverse stock split
Premium
The Fly
Valion Bio announces 1-for-25 reverse stock split
27d ago
Valion Bio’s regulatory dossier for Entolimod  accepted for review in Ukraine
PremiumThe FlyValion Bio’s regulatory dossier for Entolimod accepted for review in Ukraine
2M ago
Valion Bio files to sell 29.41M shares of common stock, warrants
Premium
The Fly
Valion Bio files to sell 29.41M shares of common stock, warrants
2M ago
Valion Bio advances Entolimod platform and manufacturing scale-up
Premium
Company Announcements
Valion Bio advances Entolimod platform and manufacturing scale-up
2M ago
Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform
PremiumThe FlyValion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform
4M ago
Valion Bio reports Q1 EPS ($2.23)  vs. ($2.52) last year
Premium
The Fly
Valion Bio reports Q1 EPS ($2.23) vs. ($2.52) last year
4M ago
Valion Bio receives first study protocol under agreement with NIAID
Premium
The Fly
Valion Bio receives first study protocol under agreement with NIAID
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100